110
Participants
Start Date
March 1, 2022
Primary Completion Date
February 4, 2024
Study Completion Date
February 4, 2024
Canvas Dx
Canvas Dx is intended for use by healthcare providers as an aid in the diagnosis of autism spectrum disorder (ASD) for patients ages 18 months through 72 months who are at risk for developmental delay based on concerns of a parent, caregiver, or healthcare provider. The device is not intended for use as a stand-alone diagnostic device but as an adjunct to the diagnostic process. The device is for prescription use only (Rx only)
ECHO Autism, Columbia
University of Missouri-Columbia
OTHER
Cognoa, Inc.
INDUSTRY